Acrivon Therapeutics, Inc. Common Stock (ACRV) — Net Asset Quality Index
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a Net Asset Quality Index of 88.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $145.30 Million minus total liabilities of $16.70 Million yields net assets of $128.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Acrivon Therapeutics, Inc. Common Stock defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Acrivon Therapeutics, Inc. Common Stock Net Asset Quality Index Over Time (2020–2024)
This chart shows how Acrivon Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the index stands at 88.5%, representing net assets of $128.60 Million against total assets of $145.30 Million USD. Explore Acrivon Therapeutics, Inc. Common Stock (ACRV) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Acrivon Therapeutics, Inc. Common Stock (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for Acrivon Therapeutics, Inc. Common Stock from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Acrivon Therapeutics, Inc. Common Stock market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.9% | $176.79 Million | $196.59 Million | $19.80 Million | ▲ +2.3 pp |
| 2023 | 87.7% | $121.19 Million | $138.26 Million | $17.07 Million | ▼ -6.4 pp |
| 2022 | 94.1% | $170.47 Million | $181.23 Million | $10.75 Million | ▲ +116.4 pp |
| 2021 | -22.3% | $-23.81 Million | $106.59 Million | $130.40 Million | ▲ +362.7 pp |
| 2020 | -385.0% | $-8.41 Million | $2.19 Million | $10.60 Million | — |